MYC and Miyoshi myopathy: A significant variation was observed in the onset to progression to MM due to genetic factors involving del(17p), t(4;14), myelocytomatosis viral oncogene homolog (MYC) translocations [22], gain(1q) [23,24], and gene expression profile (GEP) risk score [25].